http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872081-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c743184ad2c5bec8f25fab02ca247776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53fc3f6f73b11195a9b690e3a8364f09 |
publicationDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102872081-B |
titleOfInvention | Application of Houttuynoid C in drugs for treating gastric cancer |
abstract | The invention discloses an application of Houttuynoid C in drugs for treating gastric cancer, belonging to the technical field of a new application of drugs. Through external MTT (Methyl Thiazolyl Tetrazolium) antineoplastic activity evaluation, the invention discovers that Houttuynoid C also has an obvious inhibition effect on the growth of human gastric cancer strains HGC-27, MGC-803, BGC-823 and SGC-7901. Thus, Houttuynoid C can be applied to preparing anti-gastric cancer drugs and has good development and application prospects. The application of Houttuynoid C in drugs for treating endometrial cancer disclosed by the invention is publicized for the first time; and as the skeleton type is brand new, Houttuynoid C has an unexpectedly strong inhibitory activity to gastric cancer cells. |
priorityDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.